TipRanks
Go Ultimate55% OFF

MediPharm Labs (MEDIF) Ownership - Who Owns MediPharm Labs?

MediPharm Labs (MEDIF) Ownership Overview

  • 9.51% Insiders
  • 90.49% Public Companies and Individual Investors

The ownership structure of MediPharm Labs (MEDIF) stock is a mix of institutional, retail, and individual investors. , 9.51% is owned by Insiders, and 90.49% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jun 12, 2026Christopher David TavesC$13,259

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

MEDIF top shareholders
Holder# of SharesType% HoldingValue
David Pidduck22,794,570Insider5.34%1,094,139
Keith Strachan9,993,997Insider2.34%479,712
Gregory Edison Hunter3,093,008Insider0.72%148,464
Christopher David Taves2,847,939Insider0.67%136,701
Michael Scott Bumby637,877Insider0.15%30,618
Christopher John Halyk528,906Insider0.12%25,387
Shelley Potts310,223Insider0.07%14,891
John Medland253,659Insider0.06%12,176
Emily Jameson163,480Insider0.04%7,847

FAQ

What percentage of MediPharm Labs (MEDIF) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.49% of MediPharm Labs (MEDIF) stock is held by retail investors.
Who owns the most shares of MediPharm Labs (MEDIF)?
David Pidduck owns the most shares of MediPharm Labs (MEDIF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.